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Introduction
The French Paradox, a term coined by Serge Renaud in 1986, 
has stymied scientists for years. The paradox is presented by the 
fact that France  is one of the world’s  highest consumers of sat-
urated fat and cholesterol-containing foods.  Yet, as a whole, the 
French people have lower rates of coronary heart disease than 
the rest of the Western world (cited in Ferrieres, 2004; cited in 
Agarwal, 2002). This presents a paradox since it has been firm-
ly established that large amounts of cholesterol and saturated 
fat increase the risk for Coronary heart disease (Shestov, et 
al, 1993). How could a nation that consumes more cholesterol 
and saturated fats than the United States of America still have a 
significantly lower CHD mortality rate?
One possible explanation for this conundrum was proposed in 
1986: the French have a larger intake of alcohol consumption 
than Americans. It was, therefore, hypothesized that alcohol, 
through various biological mechanisms, can lower the risk for 
Coronary heart disease (Rimm, 1999). The detrimental effects 
of alcohol have been tested and proven. However, most of these 
terrible effects stem from long term alcohol abuse and binging. 
Perhaps viewing alcohol from a moderate intake perspective 
will present different data. The purpose of this paper is to re-
search and assess this hypothesis to determine if a moderate in-
take of alcohol has a deterrent effect on coronary heart disease.
Method
This is a meta-analysis of more than twenty papers including many 
original experiments. The information gathered in this paper has 
been collected from numerous sources including databases such 
as PROquest and JSTOR. Additionally, a great deal of information 
was gathered from medical journals publicly available on the in-
ternet or in libraries. All of this information was read, analyzed, 
and compared to determine each piece’s respective authority 
and veracity. Each article was also assessed in accordance with its 
respective levels of diversity and sample size significance.
Results
In this review, the words “moderate intake of alcohol” will be 
used. This term obviously excludes excessive consumption of 
alcohol as well as total abstinence from alcohol. For laypeople, 
the term “moderate intake of alcohol” has a wide and subjective 
purview that will always fall somewhere between abstinence and 
excessive alcohol consumption.  For the purposes of the ex-
periments referenced herein, moderate intake of alcohol refers 
to 15-30 milligrams of ethanol (the alcohol found in what are 
commonly considered alcoholic beverages, such as beer, wine 
and spirits) per day. This is the amount typically contained in one 
to two alcoholic beverages.  Any alcoholic consumption below 
or above 15-30 milligrams may have similar effects. However, 
this level of consumption it is not within the purview of this 
research paper. 
When focusing on the intake of a moderate amount of alcohol 
(15-30 mg of ethanol), several experiments have found positive 
effects that alcohol exerts, directly or indirectly, on coronary 
heart disease. Graphically, it is represented as a J or U shaped 
curve. Below is a summary of the effects of alcohol on relative 
risk of death (Tabl1 1). Some experiments show that moderate 
levels of alcohol intake will decrease the risk of coronary heart 
disease by as much as 20 to 30 percent ( Rimm et al, 1999b; 
Emberson & Bennett, 2006; Pearson, 1996). There are numerous 
mechanisms proposed for this decreased risk. Some have great-
er scientific support than others. This paper will present those 
mechanisms that have sufficient scientific ground upon which to 
stand. The various mechanisms that will be discussed are:
High-density lipoprotein increase; Apolipoprotein A-1 and A-2 
increase; Change in lipoprotein size; Increase in fibrinolytic ac-
tivity; Decrease in fibrinogen; Decreases in platelet aggregation; 
and Increasing insulin sensitivity.
Apolipoprotein A-1 A-2 Increase
In a process similar to High density lipoprotein increase, mod-
erate intake of alcohol is hypothesized to increase the transport 
rates and concentration of  Apolipoproteins A-1 and A-2. These 
proteins are produced in the liver and are  part of the large 
complex of HDL that helps start the process of removal of “bad 
cholesterol” from the blood stream by HDL ( De Oliveira e 
Silva et al, 2000; van der Gaag et al, 2016; Frank & Marcel, 2000). 
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There are two primary ways that Apolipoproteins assist in the 
removal of bad cholesterol: 
First, in particular, Apolipoprotein A-1 is a cofactor for the en-
zyme lecithin cholesterol acyltransferase (LCAT) which con-
verts cholesterol into cholesterol esters (http://www.ncbi.nlm.
nih.gov/gene/335; Frank & Marcel, 2000). The cholesterol esters 
are more hydrophobic and help form the sphere of HDL that 
gets transferred in one of two ways: directly, through specif-
ic HDL receptors to the liver; or indirectly through very low 
density lipoprotein (VLDL) and intermediate density lipoprotein 
(IDL) conversion. Therefore, an increase in the concentration 
and transport rates of Apolipoproteins A-1 and A-2 will speed 
up the process by which the HDL will esterify and remove cho-
lesterol from the blood. 
Second, in addition to its role in speeding up the rate of cho-
lesterol removal by HDL, Apolipoprotein A-1 has also been 
associated with prostacyclin stabilizing factor, which is involved 
in anticlotting. By stabilizing prostacyclin, better known as 
Prostaglandin I2 (PGI-2), platelet aggregation is inhibited which 
helps decrease the chance of clots forming. The positive effects 
of inhibiting platelet aggregation will be discussed in more detail 
later in this paper (Yui et al, 1988).
Change in Lipoprotein Size
Experiments have also shown that ethanol can increase particle 
size of HDL and LDL. Small, dense LDL’s have been associated 
with a  risk of Coronary heart disease of three times that of an 
individual with large “fluffy” LDL. Additionally, an increase in the 
size of these lipoproteins has been associated with cardiopro-
tection (Mukamal et al, 2007).
All of the above mechanisms  hypothesize  how alcohol cre-
ates a potential downgrade of risk for heart disease based upon 
changes in lipid profile. More particularly, these hypotheses are 
based upon increases in HDL-Cholesterol and Apolipoprotein 
concentrations as well as lipoprotein size.
The Hemostasis Hypothesis
The next set of  mechanisms that hypothesize how moderate 
alcohol consumption has a possible downgrade on heart disease 
are based on  hemostasis. Put simply, these hypotheses suggest 
that alcohol affects the way the blood clots and breaks down 
clots, thereby reducing the risk for coronary heart disease. 
One possible hemostatic mechanism proposed is that moderate 
intake of alcohol can decrease fibrinogen concentration (Mennen 
et al, 1999 Stec et al, 2000). Experiments have shown that the 
moderate intake of alcohol decrease the levels of circulating fi-
brinogen by 18-20 percent (Wang, Barker, & Fuller, 1999). This 
decrease can cause a significant reduction of the risk for cor-
onary heart disease. Fibrinogen is a blood soluble plasma pro-
tein that is activated by the enzyme thrombin and produces the 
protein fibrin. Elevated levels of fibrinogen in the blood can lead 
to potentially devastating effects on the heart. First, it can cause 
an increase in platelet aggregation. Second, it will increase fibrin 
levels which promote coagulation, which leads to an increase in 
blood clotting. Third, elevated levels of fibrinogen increase plas-
ma viscosity, which is associated with an increased severity of 
coronary heart disease (Junker et al, 1998; Stec et al, 2000), In 
some scenarios, these factors can cause acute clot formation and 
block arteries, including coronary arteries, leading to myocardial 
infarctions. Finally, elevated fibrinogen levels play a role in ath-
erosclerotic plaque build up.  A moderate intake of alcohol will 
decrease  fibrinogen levels thereby decreasing the above factors. 
On the  antonymic aspect, alcohol has been proven to increase 
the levels of fibrinolytic activity (Pikaar et al, 1987; Aikens et 
al, 1998; Sierksma et al, 2001). In addition to alcohol decreas-
ing fibrin building, it is also able to increase fibrin catalysis. 
Experiments have shown that moderate levels of alcohol can in-
crease levels of plasminogen activator, which converts plasmino-
gen to plasmin, one of the enzymes that catalyzes fibrin clots. As 
a result, the hemostatic process of fibrinolysis is increased. By 
increasing the fibrinolytic activity in the body, clots are less like-
ly to form thereby reducing strokes and ischemic incidents. In 
fact, many medications that treat heart diseases work through 
similar mechanisms by inhibiting Plasminogen activator inhibi-
tor-1, which acts exactly as its name indicates -- by inhibiting the 
inhibitor, the activator is increased (Vaughan, 2011).
Another hemostatic aspect of moderate alcohol intake is its 
effect on platelet aggregation. Experiments have shown that al-
cohol can decrease platelet aggregation, subsequently decreas-
ing the risk of cardiac incidents (Zhang et al, 2000; Pikaar et 
al, 1987; Renaud & Ruf, 1996, Parson,1996). Platelet aggregation 
is a pivotal player in controlling and carrying out hemostasis. 
Moreover, it is a significant factor when it comes to athersle-
rotic heart disease. Atherosclerosis starts with the oxidation of 
lipoproteins which are responsible for creating lesions on the 
arterial wall. These lesions expose the endothelium thereby al-
lowing platelet receptors to open to accepting signals that allow 
platelets to begin adhering to one another. Platelets are also re-
sponsible for amplifying the signal that attracts leukocytes such 
as monocytes and lymphocytes. These cells have been previous-
ly proven to advance atherosclerosis through many mechanisms 
including the uptake of cholesterol up to the point of rupturing. 
Additionally, platelets contain chemokines within them that are 
released when platelets are activated. These chemokines are 
also factors that play a role in the propagation of ahterslerosis 




Alcohol has been shown to increase insulin sensitivity in in-
sulin resistant individuals.  (Sierksma et al, 2003; Joosten et al, 
2008; Fachinni, Chen, & Reaven, 1994). There is a correlation 
between these individuals and higher risk for coronary heart 
disease. The precise mechanisms for this correlation are un-
known but hypothesized as follows (Sparks, Sparks, & Adelhi, 
2012). In one hypothesis, muscle and fat tissue resistance to 
insulin causes an increase in plasma insulin and free fatty acid 
concentrations. Subsequently, this deadly combination will lead 
to Very low density lipoprotein (VLDL)-triglyceride secretion , 
which leads to higher triglyceride plasma levels. Another pos-
sible hypothesis suggested is that in insulin resistant individu-
als, there is a defect that does not allow insulin to properly 
regulate VLDL-triglyceride secretion thereby leading to hyper-
glyceridemia. In both of these mechanisms, the end result is an 
increase in triglycerides found in the plasma which, through an 
additional mechanism, is associated with coronary heart disease 
(Hokanson, 2002).
Discussion
Many scientists disagree with these hypotheses set forth above. 
Some attack the conclusions themselves while others question 
the experiments based on external biases and statistical errors. 
One proposed argument is that the control group of abstainers 
from alcohol in the experiments had been tainted by ex-drink-
ers who became abstainers due to health risks. These individ-
uals either realized themselves or were directed by medical 
providers that they had to stop drinking for their overall health 
and/or their potential for a cardiac event. If this were true, then 
using these individuals as the control for the experiments would 
completely ruin the results as these individuals are much more 
prone to having cardiac problems due to their previous con-
sumption.  However, this contention has been accounted for in 
many experiments. The experiments have made sure that their 
control groups consisted of individuals who have never been 
excessive drinkers as well as others that  have been lifelong 
abstainers from alcohol.
Another potential problem that has been raised concerning  the 
experiments is the determination of what type of people make 
up the moderate alcohol intake group. The concern is that per-
haps individuals who are moderate drinkers of alcohol come 
from healthier homes or have healthier lifestyles. These con-
cerns extend to the possibility that they have potentially better 
exercise routines, higher education, and better health insurance.
With regard to the claims of cardioprotection by HDL increas-
es, there is some question as to whether increasing HDL will 
even have any impact in cardiac incidents.  According to Dr. 
Daniel Keene, pharmacologically increasing HDL and its effects 
did not improve the individual’s risk for cardiac incidents (Keene 
et al, 2014). Now, this is strongly contended by many other ex-
periments and it would seem likely that there is some other 
explanation for why Dr, Keene did not find any improvement 
in his experiments. However, this is a curious experiment that 
should be taken into account.
All in all, there is sound evidence and scientific proof to say 
with confidence that alcohol exerts some level of cardiopro-
tection by increasing HDL concentrations, in particular the 
HDL2 and HDL3 subfractions. The mechanism behind this is 
not fully understood. However, the hypotheses reported above 
may shed some light on this area. The experiments supporting 
the cardioprotective effects of moderate alcohol use have been 
performed with significant numbers of subjects representing all 
people of all races, sexes and socioeconomic backgrounds. There 
have been over 40 experiments proving this point. Granted that 
some of these experiments do have some faults and biases with 
patients, but taken as a whole, the experiments clearly indicate 
a significant cardioprotective trait of alcohol. However, this only 
accounts for roughly 50 percent of alcohol’s cardioprotection.
Regarding the other 50 percent of cardioprotection, there is 
also sound basis to say that alcohol will decrease circulating 
fibrinogen, increase fibrinolytic activity, and decrease platelet 
aggregation. All these factors have been proven  by proper 
scientific experimentation. Although some may contest these 
results because a few of the experiments were conducted in 
vitro and not on people, the results were sound and the newer 
experiments have verified this to be true.
With regard to increasing insulin sensitivity there is a lot un-
known about the mechanisms by which insulin resistance harms 
the cardiovascular system and how alcohol increases sensitivity. 
However, from all the experiments it would seem clear that 
there is an increase in the sensitivity even if we are not clear 
about how it happens.
Conclusion
Based on all the evidence and experimentation is seems evident 
that there are benefits to moderate alcohol intake. To go so far 
as to recommend alcohol as a remedy or even a supplement to 
those in risk of coronary heart disease does not fall under the 
purview of this paper. It may be true that alcohol will reduce 
the risks for heart disease up to 30 percent.  However, we need 
to be cognizant of the potential risk and damage that alcohol 
may cause on other parts of the body. To summarize, medical 
professionals should not be so quick to dismiss alcohol as a 
deadly drug, rather they should research and weigh the cost 
versus benefit and advise their patients accordingly. 
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It would seem clear that since alcohol has cardioprotective 
attributes, the French paradox is not very paradoxical. The 
French diet includes a consistent moderate intake of alcohol, 
which would explain the lower coronary heart diseases rate in 
France.  Although this may not be the only explanation for why 
the French cardiac mortality rate is much lower, alcohol intake 
is proven to be a valid hypothesis.
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